主权项 |
1. A method for treating a human individual at risk of developing cardiomyopathy (CMP) or ischemic heart disease (IHD) comprising: administering to said human individual glutathione S-transferase P1 (GSTP1) in an amount effective to reduce the risk of CMP and/or IHD, wherein the human individual is:
a patient that has been diagnosed with myocarditis or hypertension, a patient that has suffered a myocardial infarction, a patient that has been diagnosed with angina pectoris, a patient with heart insufficiency or heart failure, and/or a patient that suffers from a failing myocardium. |